热门资讯> 正文
肿瘤坏死制药将执行反向股票拆分
2025-08-28 21:28
- TNF Pharmaceuticals (NASDAQ:TNFA) plans to execute a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares to obtain compliance with Nasdaq's listing standards.
- The reverse stock split will reduce the number of shares of the company’s common stock outstanding as of August 27, 2025, from 178,615,658 shares to 1,786,157 shares. The common stock will begin trading on a split-adjusted basis upon market open on September 2, 2025.
- TNFA --27.3% premarket to $0.0654
- Source: Press Release
More on MyMD Pharmaceuticals
- Financial information for MyMD Pharmaceuticals
风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。